Epstein-Barr virus–driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation
Science Advances · 2025
DOI: 10.1126/sciadv.adr8837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Haixi You und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Microbiology, Tufts University, Boston, MA 02111, USA. Hauptthemen laut MEDLINE: Cardiolipins, Herpesvirus 4, Human, B-Lymphocytes, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDCR NIH HHS.
Abstract (Originalsprache)
The Epstein-Barr virus (EBV) infects nearly 90% of adults globally and is linked to over 200,000 annual cancer cases. Immunocompromised individuals from conditions such as primary immune disorders, HIV, or posttransplant immunosuppressive therapies are particularly vulnerable because of EBV’s transformative capability. EBV remodels B cell metabolism to support energy, biosynthetic precursors, and redox equivalents necessary for transformation. Most EBV-driven metabolic pathways center on mitochondria. However, how EBV regulates B cell mitochondrial function and metabolic fluxes remains unclear. Here, we show that EBV boosts cardiolipin (CL) biosynthesis, essential for mitochondrial cristae biogenesis, via EBV nuclear antigen 2/MYC-induced CL enzyme transactivation. Pharmacological and CRISPR genetic analyses underscore the essentiality of CL biosynthesis in EBV-transformed B cells. Metabolomic and isotopic tracing highlight CL’s role in sustaining respiration, one-carbon metabolism, and aspartate synthesis. Disrupting CL biosynthesis destabilizes mitochondrial matrix enzymes pivotal to these pathways. We demonstrate EBV-induced CL metabolism as a therapeutic target, offering synthetic lethal strategies against EBV-associated B cell malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Microbiology, Tufts University, Boston, MA 02111, USA.
- Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA.
- Division of Signal Transduction, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Haixi You, Larissa Havey, Zhixuan Li, Yin Wang, John M Asara, Rui Guo
Förderung
- NCI NIH HHS
- NIDCR NIH HHS
Zitieren
APA
You, H., Havey, L., Li, Z., Wang, Y., Asara, J. M., & Guo, R. (2025). Epstein-Barr virus–driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation. Science Advances. https://doi.org/10.1126/sciadv.adr8837
Vancouver
You H, Havey L, Li Z, Wang Y, Asara JM, Guo R. Epstein-Barr virus–driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation. Science Advances. 2025. doi:10.1126/sciadv.adr8837
BibTeX
@article{You2025,
author = {You, Haixi and Havey, Larissa and Li, Zhixuan and Wang, Yin and Asara, John M and Guo, Rui},
title = {Epstein-Barr virus–driven cardiolipin synthesis sustains metabolic remodeling during B cell transformation},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adr8837}
}
EUVIMED